Literature DB >> 8000432

Inefficient processing of human protein C in the mouse mammary gland.

W N Drohan1, D W Zhang, R K Paleyanda, R Chang, M Wroble, W Velander, H Lubon.   

Abstract

Vitamin K-dependent plasma protein, human Protein C (HPC) has been expressed in transgenic mice, using a 4.2 kb mouse whey acidic protein (WAP) promoter, 9.0 kb HPC gene and 0.4 kb 3' flanking sequences. Expression was mammary gland-specific and the recombinant human Protein C (rHPC) was detected in milk at concentrations of 0.1 to 0.7 mg ml-1. SDS-PAGE revealed that the single, heavy and light chains of rHPC migrated with increased electrophoretic mobility, as compared to HPC. Enzymatic deglycosylation showed that these molecular weight disparities are in part due to differential glycosylation. The substantial increase observed in the amount of single chain protein, as well as the presence of the propeptide attached to 20-30% of rHPC, suggest that mouse mammary epithelial cells are not capable of efficient proteolytic processing of rHPC. The Km of purified rHPC for the S-2366 synthetic substrate was similar to that of plasma-derived HPC, while the specific activity was about 42-77%. Amino acid sequence analyses and low anticoagulant activity of purified rHPC suggest that gamma-carboxylation of rHPC is insufficient. These results show that proteolytic processing and gamma-carboxylation can be limiting events in the overexpression of fully biologically active rHPC in the mouse mammary gland.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000432     DOI: 10.1007/BF01976767

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  31 in total

1.  Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin.

Authors:  B W Grinnell; J D Walls; B Gerlitz
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

2.  Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate.

Authors:  M Dreyfus; J F Magny; F Bridey; H P Schwarz; C Planché; M Dehan; G Tchernia
Journal:  N Engl J Med       Date:  1991-11-28       Impact factor: 91.245

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model.

Authors:  A Gruber; J H Griffin; L A Harker; S R Hanson
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

5.  Amplification of multicistronic plasmids in the human 293 cell line and secretion of correctly processed recombinant human protein C.

Authors:  J D Walls; D T Berg; S B Yan; B W Grinnell
Journal:  Gene       Date:  1989-09-01       Impact factor: 3.688

6.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

Authors:  F B Taylor; A Chang; C T Esmon; A D'Angelo; S Vigano-D'Angelo; K E Blick
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  Replacement therapy with a purified protein C concentrate during initiation of oral anticoagulation in severe protein C congenital deficiency.

Authors:  V De Stefano; S Mastrangelo; H P Schwarz; P Pola; R Flore; B Bizzi; G Leone
Journal:  Thromb Haemost       Date:  1993-08-02       Impact factor: 5.249

8.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Characterization of a protein C activator from the venom of Agkistrodon contortrix contortrix.

Authors:  C L Orthner; P Bhattacharya; D K Strickland
Journal:  Biochemistry       Date:  1988-04-05       Impact factor: 3.162

10.  Treatment of coumarin-induced skin necrosis with a monoclonal antibody purified protein C concentrate.

Authors:  W Schramm; M Spannagl; K A Bauer; R D Rosenberg; B Birkner; Y Linnau; H P Schwarz
Journal:  Arch Dermatol       Date:  1993-06
View more
  15 in total

Review 1.  The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins.

Authors:  A J Clark
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-07       Impact factor: 2.673

2.  Comparable processing of beta-lactoglobulin pre-mRNA in cell culture and transgenic mouse models.

Authors:  G Donofrio; E Bignetti; A J Clark; C B Whitelaw
Journal:  Mol Gen Genet       Date:  1996-09-25

3.  Recombinant human protein C expression in the milk of transgenic pigs and the effect on endogenous milk immunoglobulin and transferrin levels.

Authors:  K E Van Cott; H Lubon; F C Gwazdauskas; J Knight; W N Drohan; W H Velander
Journal:  Transgenic Res       Date:  2001       Impact factor: 2.788

4.  Phenotypic and genotypic stability of multiple lines of transgenic pigs expressing recombinant human protein C.

Authors:  K E Van Cott; H Lubon; C G Russell; S P Butler; F C Gwazdauskas; J Knight; W N Drohan; W H Velander
Journal:  Transgenic Res       Date:  1997-05       Impact factor: 2.788

5.  Swine PPAR-γ2 expression upregulated in skeletal muscle of transgenic mice via the swine Myozenin-1 gene promoter.

Authors:  Juanjuan Ma; Jin Chai; Yangyang Shang; Yujiao Li; Ran Chen; Jia Jia; Siwen Jiang; Jian Peng
Journal:  Transgenic Res       Date:  2014-11-25       Impact factor: 2.788

6.  Ectopic overexpression of swine PPARγ2 upregulated adipocyte genes expression and triacylglycerol in skeletal muscle of mice.

Authors:  Jinliang Huang; Yuanzhu Xiong; Ting Li; Lin Zhang; Zijian Zhang; Bo Zuo; Dequan Xu; Zhuqing Ren
Journal:  Transgenic Res       Date:  2012-04-19       Impact factor: 2.788

7.  Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice.

Authors:  F Yull; G Harold; R Wallace; A Cowper; J Percy; I Cottingham; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

8.  Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin.

Authors:  R Drews; R K Paleyanda; T K Lee; R R Chang; A Rehemtulla; R J Kaufman; W N Drohan; H Luboń
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Renal tubule-specific expression and urinary secretion of human growth hormone: a kidney-based transgenic bioreactor growth.

Authors:  Xinhua Zhu; Jin Cheng; Liwei Huang; Jin Gao; Zhong-Ting Zhang; Joanne Pak; Xue-Ru Wu
Journal:  Transgenic Res       Date:  2003-04       Impact factor: 2.788

10.  Transgenic mice expressing recombinant human protein C exhibit defects in lactation and impaired mammary gland development.

Authors:  Carol A Palmer; Henryk Lubon; James L McManaman
Journal:  Transgenic Res       Date:  2003-06       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.